Product Name: Teriparatide
CAS No: 52232-67-4
Purity: 95%
Molar Mass: 4117.72
Chemical Formula: C181H291N55O51S2
Synonyms: LY 333334, Osteotide, Movymia
Storage: Store at -20℃
Sequence: SVSEIQLMHN LGKHLNSMER VEWLRKKLQD VHNF
Target: PTH1 RA
Application: Teriparatide (CAS: 52232-67-4) stands as a pivotal pharmaceutical agent in the realm of osteoporosis management. As a recombinant form of parathyroid hormone (PTH), teriparatide plays a crucial role in bone metabolism and calcium homeostasis. Its mechanism involves intermittent administration, stimulating osteoblast activity and enhancing bone formation. By promoting bone mineral density and bone strength, teriparatide is instrumental in reducing the risk of fractures in individuals with severe osteoporosis. This targeted approach to bone health makes teriparatide a valuable therapeutic option, especially for those who have not responded well to other treatments. In the field of pharmaceuticals, teriparatide exemplifies a strategic intervention to address the challenges of osteoporosis and promote skeletal health effectively.
